The erythrocytes from the father showed normal results both in GSH con tent and in the GSH stability test.
The results of assay for G6PD activity in erythrocytes were shown in Fig.   3 . The erythrocytes from the patient showed a very low activity as compared with that from the controls. The erythrocytes from the mother showed a mode rate degree of deficiency of G6PD, while those of the father were within normal limits. After the treatment with vitamin B12 for three weeks , GSH in erythrocytes from the patient showed an increase form 43.6 to 54.0 mg/100 ml of erythrocytes and an improvement of the GSH stability test , while the activity of G6PD re mained in low level as observed in the pre-treatment stage . The concentration of vitamin B12 in the blood of the patient was 0.42 my/ml , within normal limits on admission and showed a marked rise 13.55 in during the treatment with vitamin B12. The hemolytic process and its relation to these three abnormalities; low content of GSH, decreased GSH stability, and deficiency of G6PD in the erythro cytes, has been explained as follows (Fig. 5) .
Although biochemical mechanism of hemolysis is not enough understood, there are several evidences showing that GSH plays an important role in the maintenance of structural integrity of erythrocyte. Benesch22) observed that the hemolysis induced by organic mercury compounds was protected by the previous addition of GSH in in-vitro experiments. Fegler23) showed an inverse correlation between GSH content of horse erythrocytes and rate of spontaneous hemolysis of them. Since GSH is thought to activate a wide variety of enzyme systems, concerning carbohydrate , fat, and protein metabolism, by protecting the enzymes against their oxidation 24)15), it is reasonable to presume that GSH is essential for the viability of the cell and for the maintenance of structural inte grity of cell. The fact", )27) that glutathione exists exclusively inside the cell might support the concept mentioned above. In normal erythrocytes the maintenance of GSH is thought to be dependent on the oxidative metabolism of glucose. The conversion of oxidized glutathione (GSSG) to GSH requires the participation of reduced triphosphopyridine nucleotide (TPNH) which is generated from TPN by G6PD in the process of conversion of glucose-6-phosphate to 6
phosphogluconate. Therefore, the deficiency of G6PD results in limitation of conversion of GSSG to GSH (Fig. 5 ). When the individuals having a defect in GOD in erythrocytes are exposed to a certain drug , the manifestation of hemol ytic anemia is thought to take place by the marked decrease of GSH in erythro cytes as a consequence of aggravation of preexisting metabolic disturbance . The enzyme defect in drug-induced hemolytic anemia is said to be determined genetically.28) The agents, which can induce this type of hemolytic anemia, include primaquine '29 ) quinidine,30) sulfanilamide 17), nitrofurantoin ,37) furaz olidone,32) naphthalene, 33) phenacetin .34) and fava bean.35) Irrespective of the kind of these drugs, the actual cause of hemolysis of sensitive individuals should be attributed to the deficit in G6PD in the erythrocytes . Larizza3fi) has proposed to designate "enzyme-deficiency hemolytic anemia" for this type of the disorder induced by pharmacological or vegetable agents . Recently, Shahidi and Diamond") reported that the same enzyme deficiency , as observed in the drug-induced hemolytic anemia , was found in two siblings of congenital nonspherocytic hemolytic anemia without any exposure to drugs . They described that the erythrocyte deficient in G6PD did not necessarily require the injurious effect of a drug to undergo hemolysis .
We suppose that both so-called congenital nonspherocytic hemolytic anemia and drug-induced hemolytic anemia are considered as the same entity belonging to an "inborn error of metabolism" and that the former is the case in which the manifestation of hemolysis develops soon after birth without exposure to drug and the latter is the case in which drug accentuates a preexisting metabolic dis turbance to lead the manifestation of hemolysis .
W e could demonstrate a lower content of GSH , its instability by incubation with APH, and a deficiency of GOD in erythrocytes in our infant diagnosed as congenital nonspherocytic hemolytic anemia. This was the first case reported in Japan of hemolytic anemia in which this type of enzymatic abnormality in the erythrocytes was demonstrated. It is of interest that jaundice of our patient showed a marked improvement by the treatment with massive dose of vitamin B12. Not only the improvement of clinical symptoms but a rise of GSH content and improvement of GSH in stability in erythrocytes were observed in convalescence, while the activity of GOD remained in a low level in spite of the treatment. The beneficial effect of vitamin B12 on hemolytic jaundice in our case might show a close relation be tween vitamin B12 and glutathione metabolism. The effect of vitamin B12 on the reduction of some S-S compounds to the SH-state was observed by Dubnoff38) with in-vitro enzyme system. Ling and Chow" reported that the concentration of SH-compounds, chiefly GSH, in erythrocytes was increased by the administra tion of vitamin B12 in vitamin B12 deficient rats and in the patients with pernicious anemia. A lower content of GSH in erythrocytes was found in rats40) or chicks41) deficient in vitamin B12 and the supply of vitamin B12 caused an increase of GSH. Although the exact site of vitamin B12 on glutathione meta bolism is obscure, it has been suggested that vitamin B12 serves to keep gluta thione in the reduced form through its participation in reductive severance of -S-S bond") or to incorporation of glycin into glutamylcystein in glutathione formation .42) The deficiency of vitamin B12 was not recognized in our patient since the concentration in blood was within normal limits on admission. The present data, however, indicate that massive dose of vitamin B12 was effective for remission of hemolytic jaundice and that this effect might be attributed to an increase of GSH and an improvement of its instability in erythrocytes after vitamin B12 treatment. In this respect, an in-vitro experiment was made to observe whether or not vitamin B12 would promote GOD activity in erythrocytes. As the result of this experiment no effect of the vitamin was recognized on G6PD activity (Fig. 4) . This is in agreement with the result that the activity of GOD remained unchanged in low level in spite of treatment with vitamin B12 while a marked increase of the vitamin was observed in the blood. Although the maintenance of GSH in erythrocytes would mostly depend on the activity of GOD, it is possible that some other mechanism might take a part in the mainte nance of GSH. According to Carson 42), glutathione reductase can utilize DPNH as well as TPNH as coenzyme. There is a report that glutathione reductase in primaquine-sensitive erythrocytes had an increased activity rather than normal.43) For the explanation of the beneficial effect of vitamin B12 upon hemolytic jaundice observed in the present case, the following three possibilities might be supposed : 1) Vitamin B12 accelerates directly glutathione reductase, 2) vitamin B12 ac celerates glutathione reductase indirectly by supplementing coenzyme through DPN dependent pathway in glycolysis, or 3) vitamin B12 acts on blocking the oxidation of GSH, the vitamin thus causing an increase of GSH and its stabi lity as demonstrated in this paper. The elucidation of these supposition should await further investigation.
Another interest of the present case is genetic pattern. It has been mention ed that the enzymatic defect in erythrocytes of this type of hemolytic anemia may be transmitted as a sex-linked gene of intermediate dominance. The de monstration of enzyme deficiency in our patient, the presence of the same lesion to a lesser degree in her mother, and the absence of the defect in her father seems to agree with the genetic concept. Although a maternal cousin (a) was probably affected by the same lesion, it is possible to presume that the lesion was transmitt ed not from paternal side (A) but from maternal side (A') who came of the same kinship (Fig. 1) . If this supposition is correct, the genetic pattern that the gene is carried by female might be accepted. It suggests a severer lesion because of hemizygote that the brother of the patient and her male cousin (a) died in early infancy. The deficiency of GOD was milder in our patient as compared with Shahidi's cases, brothers. This difference might be explained by sex-difference, provided the abnormality is sex-linked. As seen from the pedigree of the present case (Cf. Fig. 1 ), the distribution of the affected gene is not always clear because of unaccuracy of statement by the parents. It is difficult to trace the genetic transmission without biochemical examinations, as a milder degree of enzyme defect and anemia were only disclosed by examinations in the mother who ap peared to be normal. The manifestation of hemolysis may depend on the sev erity of gene penetrance on one hand and on the oppotunity such as infection or exposure to certain drugs which aggravate preexisting metabolic defect in the mildly affected case on the other hand. SUMMARY 1) A case of congenital nonspherocytic hemolytic anemia was reported . A metabolic abnormality in the erythrocytes from the patient was demonstrated , consisting of a low content of reduced glutathione, an abnormality in the reduced glutathione stability test, and a low activity of glucose-6-phosphate dehydro genase. These abnormalities were also found in the erythrocytes from the mother to a milder degree, while there was no abnormalities in the erythrocytes from the father. This is the first case in Japan, of this type of hemolytic anemia in which an enzymatic anomaly of the erythrocytes was demonstrated .
2) The treatment with large dose of vitaminB12 brought about a relief from jaundice, when an increase of reduced glutathione content in the erythro cytes and an improvement of reduced glutathione instability were observed , although the activity of glucose-6-phosphate dehydrogenase in the erythrocytes remained in a constantly low level.
3) The in-vitro effect of vitamin B12 on gulcose-6-phosphate dehydrogenase was investigated. The relationship between vitamin B 12 and glutathione me tabolism was discussed. 4) Genetic mode of the disease was discussed.
